Thyroid-associated Ophthalmopathy
📧 Sign up to get email alerts when something new happens for Thyroid-associated Ophthalmopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy [Phase 3]
A Phase 3 study of IBI311 in steroid-resistant thyroid-associated ophthalmopathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Rituximab (RTX) Therapy in Patients With Active TAO [Phase 4]
Phase 4 trial of Rituximab for active thyroid-associated ophthalmopathy has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy [Phase 4]
Phase 4 clinical trial evaluating the efficacy of orbital radiotherapy for Graves' ophthalmopathy (thyroid-associated ophthalmopathy).
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]
Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Effects of Atorvastatin in Graves' Orbitopathy (GO) [Phase 2]
Phase 2 trial update evaluating the effects of atorvastatin in Graves' orbitopathy (thyroid-associated ophthalmopathy) and hypercholesterole…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Study of Therapeutic Value of Periorbital Injection of Glucocorticoid in Mild TAO [Phase 3]
Phase 3 trial investigating periorbital glucocorticoid injections for mild thyroid-associated ophthalmopathy.
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy [Phase 3]
A Phase 3 trial evaluating intravenous glucocorticoids on tearfilm in patients with thyroid-associated ophthalmopathy and dry eye syndrome h…
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: 99Tc-MDP for Thyroid-Associated Ophthalmopathy [Phase 4]
Phase 4 clinical trial update for 99Tc-MDP in Thyroid-Associated Ophthalmopathy has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-19Clinical Trial Update: Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues [Phase 3]
Phase 3 trial assessing prostaglandin analogue drops for treating soft tissue expansion in inactive thyroid eye disease (thyroid-associated …
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease [Phase 2]
Phase 2 trial of teprotumumab in active thyroid eye disease completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) [Phase 3]
Phase 3 trial assessing tocilizumab for Graves' ophthalmopathy (thyroid eye disease) has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-28Clinical Trial Update: Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections [Phase 4]
Phase 4 trial evaluating subconjunctival triamcinolone injections for upper eyelid retraction in thyroid-associated ophthalmopathy has compl…
-
CLINICAL_TRIALS trial_result · 2006-10-06Clinical Trial Update: Rituximab in the Treatment of Graves' Disease [Phase 1, Phase 2]
Clinical trial update reports on the use of Rituximab for Graves' disease and thyroid-associated ophthalmopathy in Phase 1/Phase 2 studies, …